| AUC | area under the curve |
| bw | body weight |
| Cmax | maximum (or peak) serum/plasma concentration of a drug/substance |
| CMEC | (Australian) Complementary Medicines Evaluation Committee |
| COPD | chronic obstructive pulmonary disease |
| DMSO | dimethyl sulfoxide |
| EFSA | European Food Safety Authority |
| FAO | Food and Agriculture Organization |
| FSH | follicle-stimulating hormone |
| i.g. | intragastric |
| i.v. | intravenous |
| JECFA | Joint FAO/WHO Expert Committee on Food Additives |
| LH | luteinizing hormone |
| LOAEL | Lowest observed adverse effect level |
| LOEL | Lowest observed effect level |
| MOE | Margin of Exposure |
| MSDI | Maximised Survey-derived Daily Intake |
| NOAEL | No observed adverse effect level |
| NOEL | No observed effect level |
| OECD | Organization for Economic Co-operation and Development |
| mTAMDIs | Modified Theoretical Added Maximum Daily Intakes |
| TGA | (Australien) Therapuetic Goods Administration |
| Tmax | time to reach maximum serum/plasma concentration after administration of a drug/substance |
| WHO | World Health Organization |